Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001724215-17-000001
Filing Date
2017-12-12
Accepted
2017-12-12 11:31:52
Documents
1
Effectiveness Date
2017-12-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8044
  Complete submission text file 0001724215-17-000001.txt   9092
Mailing Address 700 MAIN STREET C/O LABCENTRAL CAMBRIDGE MA 02139
Business Address 700 MAIN STREET C/O LABCENTRAL CAMBRIDGE MA 02139 (44) 747-050-8164
Combined Therapeutics, Inc. (Filer) CIK: 0001724215 (see all company filings)

EIN.: 812354801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-300496 | Film No.: 171251222